Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.41672 | 16 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.35508 | 14 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.38841 | 16 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.45457 | 21 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.32837 | 15 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.52744 | 19 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.48496 | 19 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.36999 | 16 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.34904 | 15 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.37545 | 16 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.37026 | 16 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.35735 | 16 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.37997 | 16 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.37689 | 16 |